![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
2028년까지 아시아 태평양 바이러스 유사 입자 시장 예측 – 제품 유형(간염, 암/HPV 및 고셔병), 소스(효모, 곤충 세포, 식물 및 기타) 및 애플리케이션(백신)별 코로나19 영향 및 지역 분석 및 치료제)
아시아 태평양 지역의 바이러스 유사 입자 시장은 2021년에 미화 1,01883억 백만 달러에서 미화 1,769.02달러로 성장할 것으로 예상됩니다. 2028년까지 백만 달러; 2021년부터 2028년까지 연평균 성장률(CAGR) 8.2%로 성장할 것으로 예상됩니다.
의료 시장 및 연구 기관의 다양한 주체가 제품 혁신 및 개발에 적극적으로 참여하고 있습니다. 바이러스 유사 입자의 사용은 바이오의약품 산업에서 사용되는 새로운 접근 방식입니다. 바이러스 유사 입자에는 바이러스 함량이 부족하므로 실제 바이러스 구성 요소보다 처리하기가 더 쉽습니다. VLP는 약물 전달, 영상화, 면역요법 및 진단진단을 돕는 데 사용될 수 있습니다. 예를 들어, 2020년 6월 NCBI에 발표된 연구에 따르면 VLP는 광열 치료, PET 및 CT 영상, MRI 조영제 운반체, 광학 영상, 염증 및 자가면역 질환 백신과 같은 응용 분야에서 나노입자 형태로 사용될 수 있습니다. 암 면역요법 및 소분자 약물 전달(암 치료에서). 따라서 VLP의 이러한 잠재적인 적용은 예측 기간 동안 시장 참여자에게 성장 기회를 제공할 것으로 예상됩니다.
국제통화기금(IMF) 보고서에 따르면 , 아시아 태평양 지역의 성장은 2020년에도 0%로 정체될 것으로 예상되었습니다. 이는 글로벌 금융 위기(4.7%)와 아시아 금융 위기(1.3%)를 포함하여 거의 60년 만에 최악의 성장 성과였습니다. 한국의 경우 3.5%에서 하향 조정폭이 상당했지만, 호주, 뉴질랜드, 태국에서는 9%에 달하는 장기간의 생산 중단을 최소화해 코로나바이러스의 느린 확산을 관리하는 것으로 나타났습니다. 이들 국가는 전세계 관광업 폐쇄와 호주의 경우 원자재 가격 하락으로 인해 큰 타격을 입었습니다. 현재 코로나19 백신이 개발되고 있는 아시아태평양 지역에는 한국, 중국, 일본, 태국, 베트남이 포함된다. 이 중 중국은 15개 백신을, 인도와 한국은 3개 백신을, 일본은 2개 백신을, 태국과 베트남은 1개 백신을 보유하고 있다. 이들 백신 중에는 불활성화 백신 10종, 단백질 아단위 백신 6종, 바이러스 벡터 백신 7종, 핵산 백신 6종이 포함된다. 또한 안전하고 공평하며 효과적인 백신을 홍보하는 것이 아시아 태평양 지역의 최우선 과제입니다. 아시아 개발 은행(Asian Development Bank)의 보고서에 따르면, 2020년 12월 아시아 개발 은행(ADB)은 개발 회원국에 신속하고 공평한 지원을 제공할 APVAX(Asia Pacific Vaccine Access Facility)와 함께 미화 90억 달러 규모의 백신 이니셔티브를 시작했습니다. 효과적이고 안전한 코로나19 백신을 조달하고 제공하기 위한 국가(DMC)입니다. 백신 접종을 통해 바이러스 전파 사슬을 끊고 생명을 구하며 전염병의 부정적인 영향을 완화할 수 있습니다.
새로운 기능과 기술을 통해 공급업체는 새로운 고객을 유치하고 신흥 시장에서 입지를 확장할 수 있습니다. 이 요인은 아시아 태평양 바이러스 유사 입자 시장을 주도할 가능성이 높습니다. 아시아 태평양 바이러스 유사 입자 시장은 예측 기간 동안 양호한 CAGR로 성장할 것으로 예상됩니다.
2028년까지 아시아 태평양 바이러스 유사 입자 시장 수익 및 예측(미화 백만 달러)
아시아 태평양 바이러스 유사 입자 시장 세분화
아시아 태평양 바이러스 유사 입자 시장 – 제품 유형별
- 간염
- 암/HPV
- 고셔병
아시아 태평양 바이러스 유사 입자 시장 – 출처별
- 효모
- 곤충 세포
- 공장
- 기타
아시아 태평양 바이러스 유사 입자 시장 – 응용 분야
- 백신
- 치료학
아시아 태평양 바이러스 유사 입자 시장 – 국가
- 중국
- 일본 기준
- 인도
- 호주
- 대한민국
- 아시아 태평양 지역
아시아 태평양 바이러스 유사 입자 시장 – 언급된 회사
- Merck & 주식회사   ; &n bsp ;
- GlaxoSmithKline plc.
- 화이자 주식회사  ; &n bsp ;   ;
- 사노피   ;   ;
- < 스팬>인도 혈청 연구소 Pvt. Ltd.
- BHARAT 생명공학   ; &n bsp ;
- LG화학   ;   ;
- 완타이 바이오팜 범위>
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Virus-like Particles Market – By Product Type
1.3.2 Asia Pacific Virus-like Particles Market – By Source
1.3.3 Asia Pacific Virus-like Particles Market – By Application
1.3.4 Asia Pacific Virus-like Particles Market – By Country
2. Asia Pacific Virus-like Particles Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Virus-like Particles Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Experts Opinion
5. Asia Pacific Virus-like Particles Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Surging Prevalence of Infectious Viral Diseases
5.1.2 Increasing Role of Virus-Like Particles in Therapeutic Developments and Studies
5.2 Market Restraints
5.2.1 Reach of Alternative Technologies for Viral Vaccine Production
5.3 Market Opportunities
5.3.1 Growing Potential Applications in Therapeutics and Diagnostics
5.4 Future Trends
5.4.1 Steady Demand for Innovative and Effective Products
5.5 Impact Analysis
6. Asia Pacific Virus-like Particles Market Analysis
6.1 Asia Pacific Virus-like Particles Market Revenue Forecast and Analysis
7. Asia Pacific Virus-like Particles Market Analysis – by Product Type
7.1 Overview
7.2 Asia Pacific Virus-like Particles Market, by Product Type, 2021 & 2028 (%)
7.3 Hepatitis
7.3.1 Overview
7.3.2 Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
7.4 Cancer/ Human Papillomavirus (HPV)
7.4.1 Overview
7.4.2 Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
7.5 Gaucher Disease
7.5.1 Overview
7.5.2 Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Virus-like Particles Market Analysis – By Source
8.1 Overview
8.2 Asia Pacific Virus-like Particles Market Share, by Source, 2021 & 2028 (%)
8.3 Yeast
8.3.1 Overview
8.3.2 Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.4 Plant
8.4.1 Overview
8.4.2 Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.5 Insect Cell
8.5.1 Overview
8.5.2 Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Virus-like Particles Market Analysis – By Application
9.1 Overview
9.2 Asia Pacific Virus-like Particles Market Share, by Application, 2021 & 2028 (%)
9.3 Vaccines
9.3.1 Overview
9.3.2 Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
9.4 Therapeutics
9.4.1 Overview
9.4.2 Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Virus-like Particles Market – Country Analysis
10.1 Overview
10.1.1 Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
10.1.1.1 Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)
10.1.1.1.4 Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)
10.1.1.1.5 Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2 China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.4 China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)
10.1.1.2.5 China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3 India Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.4 India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.5 India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4 South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.4 South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.5 South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.5 Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.4 Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.5 Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Asia Pacific Virus-like Particles Market
11.1 Impact Assessment of COVID-19 Pandemic
12. Asia Pacific Virus-like Particles Market–Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Merck & Co., Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GlaxoSmithKline plc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Pfizer Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sanofi
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Wantai BioPharm
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Serum Institute of India Pvt. Ltd.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 BHARAT BIOTECH
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 LG Chem
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)
Table 2. Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)
Table 3. Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)
Table 4. Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 5. China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 6. China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)
Table 7. China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 8. India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 9. India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 10. India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 11. South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 12. South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 13. South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 14. Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 15. Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 16. Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms: Virus-like Particles Market
LIST OF FIGURES
Figure 1. Asia Pacific Virus-like particles Market Segmentation
Figure 2. Asia Pacific Virus-like particles Market Segmentation, By Country
Figure 3. Asia Pacific Virus-like Particles Market Overview
Figure 4. Hepatitis Held the Largest Share of the Product Type Segment in Asia Pacific Virus-like particles Market
Figure 5. India to Show Significant Growth during Forecast Period
Figure 6. Asia Pacific Virus-like Particles Market, Industry Landscape
Figure 7. Asia Pacific PEST Analysis
Figure 8. Asia Pacific Virus-like Particles Market: Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific Virus-like Particles Market– Revenue Forecast and Analysis to 2028
Figure 10. Asia Pacific Virus-like Particles Market, by Product Type, 2021 & 2028 (%)
Figure 11. Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 12. Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. Asia Pacific Virus-like Particles Market Share, by Source, 2021 & 2028 (%)
Figure 15. Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Asia Pacific Virus-like Particles Market Share, by Application, 2021 & 2028 (%)
Figure 20. Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Asia Pacific Virus-like Particles Market Overview, by Country (2021)
Figure 23. Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
Figure 24. Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. China: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- Merck & Co., Inc.
- GlaxoSmithKline plc.
- Pfizer Inc.
- Sanofi
- Serum Institute of India Pvt. Ltd.
- BHARAT BIOTECH
- LG Chem
- Wantai BioPharm
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific virus-like particles market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution